跳至主要内容
临床试验/NCT01709422
NCT01709422已完成4 期

Efficacy and Safety Profiles of Sedation With Propofol Combined With Intravenous Midazolam and Meperidine Versus Intravenous Midazolam and Meperidine for Ambulatory Endoscopic Retrograde-cholangiopancreatography(ERCP).

Prince of Songkla University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
140
试验地点
1
主要终点
Procedure Related Time

研究概览

简要总结

The purpose of this study is to compare efficacy and safety of combination of propofol and midazolam with meperidine versus midazolam and meperidine for ambulatory ERCP

详细描述

ERCP is commonly done under sedation with midazolam and meperidine, however some studies showed varying outcomes of this conventional sedation for maintained sedation. Propofol is increasing used for sedation in gastrointestinal procedure owing to its rapid recovery profiles but the complications associated with propofol are not negligible.The investigators prospectively compare the efficacy, induction time, recovery time, patient satisfaction and side effect between propofol based and conventional sedations in patients undergoing ERCP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • . All outpatients aged more than 18 years who were schedule for ERCP -

排除标准

  • pregnant woman
  • emergency situation ( i.e. concomitant upper gastrointestinal bleeding, acute cholangitis )
  • American Society of Anesthesiologist ( ASA )Class IV or V
  • respiratory disease,
  • sleep apnea
  • allergy to egg or soybean
  • drug abuse( benzodiazepine, opioid agonist )
  • previous history of failure sedation

研究组 & 干预措施

Propofol

Active Comparator

both midazolam (1mg if aged <= 70 years or 0.5mg in age >70 years) and meperidine 20 mg were given intravenously at the initiation of sedation, Thereafter, an initial bolus of propofol 20 mg intravenously. Sedation was maintained with repeated dose of 5 to 10 mg propofol.

干预措施: Propofol (Drug)

Propofol

Active Comparator

both midazolam (1mg if aged <= 70 years or 0.5mg in age >70 years) and meperidine 20 mg were given intravenously at the initiation of sedation, Thereafter, an initial bolus of propofol 20 mg intravenously. Sedation was maintained with repeated dose of 5 to 10 mg propofol.

干预措施: Midazolam (Drug)

Propofol

Active Comparator

both midazolam (1mg if aged <= 70 years or 0.5mg in age >70 years) and meperidine 20 mg were given intravenously at the initiation of sedation, Thereafter, an initial bolus of propofol 20 mg intravenously. Sedation was maintained with repeated dose of 5 to 10 mg propofol.

干预措施: Meperidine (Drug)

Conventional

Active Comparator

both midazolam 2 to 5 mg and meperidine 25 to 50 mg were given intravenously at the initiation of sedation. Sedation was maintained with repeated doses of 0.5 to 1.0 mg midazolam and 5 to 10 mg meperidine.

干预措施: Midazolam (Drug)

Conventional

Active Comparator

both midazolam 2 to 5 mg and meperidine 25 to 50 mg were given intravenously at the initiation of sedation. Sedation was maintained with repeated doses of 0.5 to 1.0 mg midazolam and 5 to 10 mg meperidine.

干预措施: Meperidine (Drug)

结局指标

主要结局

Procedure Related Time

时间窗: participants will be followed for the duration of procedure, an expected average of 2.0 hours ]

(1) induction time ( the time from sedation to scope intubation ), (2) procedure time ( the time from scope intubation to scope withdrawal ) and (3) recovery time ( the time from scope withdrawal to full recovery ).The induction time, procedural time and recovery time were recorded by the nurse in the endoscopy unit.

次要结局

  • Cardiovascular Adverse Events.(participants will be followed for the duration of procedure, an expected average of 2.0 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nisa Netinatsunton

NKC Institute of Gastroenterology and Hepatology

Prince of Songkla University

研究点 (1)

Loading locations...

相似试验